PharmaCyte Biotech Inc (PMCB)

[oldmusky]

From KW on November 4, 2020:

"PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, said, “Our team of experts is developing action plans to address the clinical hold letter. Since the FDA’s letter included a lengthy list of items and several preclinical studies, at this time it’s impossible to say when the company will be in a position to submit a complete response to the FDA. One big reason for the uncertainty is because some of the preclinical studies will be performed by outside third-party laboratories. Also, we are planning to request a meeting with the FDA about some of its requests. So, this is currently a very fluid situation.”

The actual "lengthy list" giving to pmcb seems to have disappeared from the PharmaCyte website. They do not want transparency. They want false hope.

I believe the FDA rejected PMCB's request for another meeting. They want nothing to do with Leech in a Box.

In September it will be two years since the IND submission.

Gene therapies are passing this technology bye.

Aging execs playing off investor false hopes.